This type of peptide-based skincare is commonly used to support concerns such as fine lines, wrinkles, uneven texture, and reduced skin firmness
Within biochemical research environments, the peptide is frequently investigated for its interaction with cellular signalling networks and peptide-mediated regulatory pathways
May help restore firmness and improve visible tone and texture over time
Predrag Sikirics group (School of Medicine, University of Zagreb, 1991 ) Most common experimental dose in animal studies: 10 g/kg intraperitoneally or per os, daily Standard targeted pathways: VEGFR2 angiogenesis, NO synthase , 5-HT2A serotonin receptor, dopamine D2 receptor Clinical program in Croatia halted at Phase 2 (Crohns disease) WADA Prohibited List: added in 2022 to category S0 (Non-Approved Substances) Reference sources (PubMed) Sikiric P
WT) or 50 mg/kg tamoxifen for 5 days (KO)